Life Sciences

It Just Got Easier For Early-Stage Founders and Funders to Connect in New Jersey

Keiretsu | PR Newswire

PHILADELPHIA, Jan. 4, 2021 /PRNewswire/ — Today, Keiretsu Forum Mid-Atlantic announced the launch of a new chapter in Princeton, New Jersey. Keiretsu Forum is the world’s largest and most active investment community of early-stage accredited angel investors with 53 Chapters across 3 continents, including the newly minted North Jersey Chapter. “Since 2011, Keiretsu Forum Mid-Atlantic Chapters have provided resources, mentoring, and funding to entrepreneurs …

Passage Bio Announces Gene Therapy Manufacturing Research and Development Site

Passage Bio | GlobeNewswire

PHILADELPHIA, Dec. 16, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system (CNS) disorders, today announced that it has entered into a long-term lease to support Chemistry, Manufacturing and Controls (CMC) laboratory operations for the company’s gene therapy programs. The new laboratory, slated to open …

Governor Phil Murphy Announces First Tenants of The Hub in New Brunswick

The Office of the Governor of New Jersey

Project Combines Two Prominent Research Institutes and Two Major Healthcare Networks TRENTON – Governor Phil Murphy today announced Princeton University, Rutgers University, Hackensack Meridian Health and RWJBarnabas Health will be the first tenants of The Hub, a new collaborative site in downtown New Brunswick designed to foster research, entrepreneurship, innovation, and start-up incubation in New Jersey. “This project is a …

11 NJ Companies Make Deloitte’s Technology Fast 500

New Jersey Business

Eleven New Jersey companies are listed on Deloitte’s 26th annual Technology Fast 500, a ranking of the 500 fastest-growing technology companies in North America based on percentage revenue growth over three years. The highest company on the list, at No. 52, it Amicus Therapeutics Inc, a Cranbury-based biotechnology firm focused on the treatment of rare diseases. It grew revenues 3,576% from …

Pharmaceutical firm takes 55,000 sq. ft. in Ewing, Lee & Associates New Jersey says

Joshua Burd | Real Estate NJ

A pharmaceutical company has leased more than 50,000 square feet of office space in Ewing, under a newly announced transaction by Lee & Associates New Jersey. The tenant, TCG GreenChem Inc., is making its entrance to New Jersey with the commitment at 701 Princeton South Corporate Center, the brokerage team said. The firm will occupy 54,520 square feet under a …

BioCentriq opens at NJII: ‘This is a complete game-changer for N.J.’

Tom Bergeron | ROI-NJ

Cutting-edge cell and gene therapy development and clinical manufacturing center could be leader in finding cures — attracting more bio companies to state New Jersey Institute of Technology President Joel Bloom said BioCentriq is the type of company the school had in mind when it created the New Jersey Innovation Institute in 2015 as a platform for collaboration and partnerships with industry and governmental agencies. …

Cutting-Edge Cell & Gene Therapy Manufacturing Center, BioCentriq™ Opens in Newark, New Jersey

Choose New Jersey, Inc. | Press Release

Virtual ribbon cutting and tour featured remarks from New Jersey Governor Phil Murphy, FDA’s Peter Marks, as well as panel discussions with industry leaders from ARM, NIIMBL, Century Therapeutics, BioNJ, NJEDA, NJIT and NJII on the rise of Cell & Gene Therapy in New Jersey October 29, 2020 – Newark, NJ – The New Jersey Innovation Institute (NJII) and Choose New Jersey hosted …

Ori Biotech To Use $30M Series A On Cell, Gene Therapy Manufacturing Platform

Christine Hall | Crunchbase

The drug discovery pipeline can take, on average, a decade to get from the lab to the patient. Ori Biotech aims to speed up the innovation of cell and gene therapies via the manufacturing platform it is bringing to market. The London and Woodcliff Lake, New Jersey-based company is developing a platform that closes, automates and standardizes manufacturing for cell and gene …

Somerset-Based Whizai Gets $4 Million to Make Business Intelligence Easy for Pharma and Life Sciences

Esther Surden | NJ Tech Weekly

WhizAI (Somerset) has an artificial intelligence (AI) technology for the business end of the pharmaceutical and life-science industries that some observers have described as “magical.” The company recently secured an additional $4 million in funding to further scale its software offering. According to WhizAI cofounder and CEO Rohit Vashisht, he and cofounder Amitabh Patil started the company in 2017 with the …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Director of Creative & Digital Marketing
Tiffany Hess-Bennette
Creative Content Specialist